GlobalData on MSN
Johnson & Johnson to acquire Halda Therapeutics for $3.05bn
The acquisition brings Halda's candidate HLD-0915, a clinical-stage treatment for prostate cancer, into J&J's oncology ...
Investor's Business Daily on MSN
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment
Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics.
Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback